Del13q MM CLL Test
Components: Sodium Heparin Vacutainer (2ml)
Price: 1050.0 AED
Sample Condition: Bone Marrow / Peripheral blood
Report Delivery: 3-4 days
Method: FISH
Test type: Genetics
Doctor: Oncology
Test Department:
Pre Test Information: Del 13q (MM, CLL) can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details
Del[13q] refers to a genetic abnormality found in certain types of cancer, specifically in multiple myeloma (MM) and chronic lymphocytic leukemia (CLL). It is characterized by a deletion of the long arm of chromosome 13 (q arm). This deletion is associated with a poorer prognosis and may affect the response to treatment.
In multiple myeloma, Del[13q] is one of the most common chromosomal abnormalities and is often associated with other genetic abnormalities. It has been linked to more aggressive disease progression and a shorter overall survival rate.
In chronic lymphocytic leukemia, Del[13q] is also a common genetic abnormality, occurring in approximately 50% of cases. It is associated with a more favorable prognosis compared to other genetic abnormalities commonly found in CLL.
The presence of Del[13q] is often detected through genetic testing, such as fluorescence in situ hybridization (FISH), which can identify specific chromosomal abnormalities. This information is important in determining the appropriate treatment approach and predicting the patient’s response to therapy.
| Test Name | Del13q MM CLL Test |
|---|---|
| Components | Sodium Heparin Vacutainer (2ml) |
| Price | 1050.0 AED |
| Sample Condition | Bone Marrow \/ Peripheral blood |
| Report Delivery | 3-4 days |
| Method | FISH |
| Test type | Genetics |
| Doctor | Oncology |
| Test Department: | |
| Pre Test Information | Del 13q] (MM, CLL) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
| Test Details | Del[13q] refers to a genetic abnormality found in certain types of cancer, specifically in multiple myeloma (MM) and chronic lymphocytic leukemia (CLL). It is characterized by a deletion of the long arm of chromosome 13 (q arm). This deletion is associated with a poorer prognosis and may affect the response to treatment. In multiple myeloma, Del[13q] is one of the most common chromosomal abnormalities and is often associated with other genetic abnormalities. It has been linked to more aggressive disease progression and a shorter overall survival rate. In chronic lymphocytic leukemia, Del[13q] is also a common genetic abnormality, occurring in approximately 50% of cases. It is associated with a more favorable prognosis compared to other genetic abnormalities commonly found in CLL. The presence of Del[13q] is often detected through genetic testing, such as fluorescence in situ hybridization (FISH), which can identify specific chromosomal abnormalities. This information is important in determining the appropriate treatment approach and predicting the patient’s response to therapy. |
